Clinical AI in Action.

Proven | FDA Cleared | On-Premise | Cloud-Ready | Thoracic Imaging

AI imaging solutions for the early, efficient detection of lung disease.

Easily installed on institution’s existing server hardware, read on existing workstations and supports a seamless, enterprise-wide workflow.

ClearRead CT is Riverain’s transformative, concurrent read AI product that automatically detects and measures properties of solid, sub-solid and ground glass nodules by leveraging patented vessel suppression technology.
ClearRead Xray features Riverain’s patented ClearRead Xray Bone Suppress AI software that transforms a chest Xray into a soft tissue image, providing unprecedented clarity.

Machine learning technology

Machine (deep) learning: for optimized content, workflow, and results. Model-driven AI: deep neural networks augmented with accurate disease simulation.


Image processing technology

Optimized image content and image harmonization. Adaptive image normalization: robust, turn-key, future proof, enterprise-ready solutions in the Cloud or in the clinic.


Software technology and architectures

Riverain solutions use off the shelf hardware while providing seamless scalability and extensibility.

Increase your institutional effectiveness


Provides enterprise capable solutions that support unification of care across the entire enterprise.


Provides “Future Proof” solutions that seamlessly adapt to changes in hospital environments.


Provides cost effective solutions for institutions of all sizes.

Technology to aid in efficient, early detection of lung disease

Riverain Technologies is dedicated to providing software tools to aid the clinician in the efficient, effective early detection of lung disease. With Riverain’s ClearRead applications, clinicians are able to see more and detect more, faster and more effectively across the entire enterprise.
About Us